356 related articles for article (PubMed ID: 12722319)
21. Neuraminidase inhibitors for treatment of influenza A and B infections.
MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
[TBL] [Abstract][Full Text] [Related]
22. Influenza.
Hansen L
Clin Evid; 2004 Dec; (12):1095-102. PubMed ID: 15865706
[No Abstract] [Full Text] [Related]
23. Influenza.
Hansen L
Clin Evid; 2003 Dec; (10):867-74. PubMed ID: 15555125
[No Abstract] [Full Text] [Related]
24. Neuraminidase inhibitors in patients with underlying airways disease.
Williamson JC; Pegram PS
Am J Respir Med; 2002; 1(2):85-90. PubMed ID: 14720062
[TBL] [Abstract][Full Text] [Related]
25. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
Sauerbrei A; Haertl A; Brandstaedt A; Schmidtke M; Wutzler P
Med Microbiol Immunol; 2006 Jun; 195(2):65-71. PubMed ID: 16059699
[TBL] [Abstract][Full Text] [Related]
26. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
[TBL] [Abstract][Full Text] [Related]
27. Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.
Hayden F; Klimov A; Tashiro M; Hay A; Monto A; McKimm-Breschkin J; Macken C; Hampson A; Webster RG; Amyard M; Zambon M
Antivir Ther; 2005; 10(8):873-7. PubMed ID: 16430192
[TBL] [Abstract][Full Text] [Related]
28. [Influenza].
Sugaya N
Nihon Rinsho; 2003 Feb; 61 Suppl 2():135-40. PubMed ID: 12722202
[No Abstract] [Full Text] [Related]
29. Flu-fighting options: decisions, decisions...
Rosen DS
Health News; 2000 Dec; 6(12):4. PubMed ID: 11142939
[No Abstract] [Full Text] [Related]
30. Managing influenza: amantadine, rimantadine and beyond.
Fleming DM
Int J Clin Pract; 2001 Apr; 55(3):189-95. PubMed ID: 11351773
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
Hurt AC; Barr IG; Hartel G; Hampson AW
Antiviral Res; 2004 Apr; 62(1):37-45. PubMed ID: 15026200
[TBL] [Abstract][Full Text] [Related]
32. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY; Hayden FG
Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
[No Abstract] [Full Text] [Related]
33. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
[TBL] [Abstract][Full Text] [Related]
34. [Neuraminidase inhibitors are effective in influenza---if administered quickly after the debut or as prophylaxis to infected persons].
Malmvall BE
Lakartidningen; 2006 Mar 15-21; 103(11):833-6. PubMed ID: 16613110
[No Abstract] [Full Text] [Related]
35. [New preparations against influenza].
Westergren T
Tidsskr Nor Laegeforen; 2001 Feb; 121(4):466-7. PubMed ID: 11255865
[No Abstract] [Full Text] [Related]
36. Antivirals for influenza: what is their role in the older patient?
Dumyati G; Falsey AR
Drugs Aging; 2002; 19(10):777-86. PubMed ID: 12390054
[TBL] [Abstract][Full Text] [Related]
37. Antiviral agents for treating influenza.
Long JK; Mossad SB; Goldman MP
Cleve Clin J Med; 2000 Feb; 67(2):92-5. PubMed ID: 10680275
[TBL] [Abstract][Full Text] [Related]
38. Antiviral drugs prophylaxis and treatment of influenza.
Med Lett Drugs Ther; 2006 Oct; 48(1246):87-8. PubMed ID: 17051136
[No Abstract] [Full Text] [Related]
39. Neuraminidase inhibitors for treatment of influenza.
Ebell MH
Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647
[No Abstract] [Full Text] [Related]
40. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
Hurt AC; Barr IG; Komadina N; Hampson AW
Virus Res; 2004 Jul; 103(1-2):79-83. PubMed ID: 15163493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
